GlassScriptPhysician profile
Larissa Celles
NPI 1902178700
$6,680.76
in general payments reported to CMS, 2019-2025
54 companies · $1,939 in 2025
The $1,939 reported for 2025 was more than what 93% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $873 · 2022: $1,282 · 2023: $1,015 · 2024: $1,571 · 2025: $1,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,525.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $749.07 | 2022-2025 | Opdivo, Reblozyl, Opdualag |
| Celgene Corporation | $648.76 | 2021-2025 | Reblozyl |
| Emd Serono, INC. | $542.75 | 2021-2025 | Bavencio |
| Astrazeneca Pharmaceuticals LP | $503.84 | 2021-2025 | Lynparza, Tagrisso, Calquence |
| Janssen Biotech, INC. | $450.99 | 2021-2025 | Erleada, Balversa, Darzalex |
| Karyopharm Therapeutics INC. | $279.22 | 2021-2025 | Xpovio |
| Genentech USA, INC. | $271.92 | 2021-2025 | Tecentriq, Polivy |
| Regeneron Healthcare Solutions, INC. | $207.78 | 2021-2024 | Libtayo |
| Seagen INC. | $203.60 | 2021-2023 | Adcetris, Tukysa, Tivdak |
| Incyte Corporation | $188.05 | 2021-2025 | Monjuvi, Jakafi, Zynyz |
| Pfizer INC. | $186.07 | 2021-2024 | |
| Genzyme Corporation | $159.17 | 2021-2024 | |
| Exelixis INC. | $139.23 | 2023-2025 | Cabometyx |
| Blueprint Medicines Corporation | $134.24 | 2021-2025 | Ayvakit |
| Jazz Pharmaceuticals INC. | $103.95 | 2023-2025 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larissa Celles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.